Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males (CXB722-100)
This study has been completed.
CeNeRx BioPharma Inc.
Information provided by:
National Institute on Aging (NIA)
First received: December 23, 2008
Last updated: January 9, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||December 2008|
|Primary Completion Date:||December 2008 (Final data collection date for primary outcome measure)|